Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Down 5.1% in January

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 427,400 shares, a drop of 5.1% from the December 31st total of 450,500 shares. Approximately 9.1% of the shares of the stock are short sold. Based on an average trading volume of 118,600 shares, the short-interest ratio is currently 3.6 days.

Intelligent Bio Solutions Stock Down 0.6 %

Shares of Intelligent Bio Solutions stock opened at $1.75 on Tuesday. The business’s 50 day simple moving average is $1.47 and its two-hundred day simple moving average is $1.50. Intelligent Bio Solutions has a one year low of $1.00 and a one year high of $11.70.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.53) by ($0.17). Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. The firm had revenue of $872.29 million for the quarter. On average, research analysts predict that Intelligent Bio Solutions will post -1.25 EPS for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.